With the analysis among 918 patents, we discovered top 339 key players by total patent application. Boehringer Ingelheim International GmbH, MannKind Corp., Eli Lilly & Co. are dominant in this area. They take 8.71% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 31
California, United States
Patent: 25
Indiana, United States
Patent: 24
Hovedstaden, Denmark
Patent: 20
California, United States
Patent: 20
F. Hoffmann-La Roche Ltd.
Virginia, United States
Patent: 17
Massachusetts, United States
Patent: 13
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 13
With the analysis among 45 patents, we discovered top 7 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, I2o Therapeutics, Inc., Intarcia Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Massachusetts, United States
Patent: 12
Intarcia Therapeutics, Inc.
California, United States
Patent: 7
California, United States
Patent: 6
Suzhou Baifuan Enzyme Technology Co Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 507 patents applied in the last 5 years. We discover 237 most active companies in this area. The fast-growing Insulet Corp., Diamyd Medical AB, I2o Therapeutics, Inc. take 7.50% of patent filing during this period.
Massachusetts, United States
Patent: 13
Massachusetts, United States
Patent: 12
California, United States
Patent: 12
Indiana, United States
Patent: 11
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 10
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 10
Tandem Diabetes Care, Inc.
California, United States
Patent: 9
The George Institute for Global Health
New South Wales, Australia
Patent: 7
California, United States
Patent: 7
With the analysis among related 507 patents in last 5 years, we discover 187 new entrants. Insulet Corp., Diamyd Medical AB, I2o Therapeutics, Inc. are the most active new entrants in this area.
Massachusetts, United States
Patent: 13
Massachusetts, United States
Patent: 12
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 10
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 10
Tandem Diabetes Care, Inc.
California, United States
Patent: 9
California, United States
Patent: 7
The George Institute for Global Health
New South Wales, Australia
Patent: 7
Hainan Taihe Medical Technology Co., Ltd.
Hainan Sheng, China
Patent: 6
Rohto Pharmaceutical Co., Ltd.
With the analysis among 335 patents, we discovered top 93 universities and scientific research institutions by total patent application. North Carolina State University, University of Kansas Medical Center, Massachusetts Institute of Technology are dominant in this area. They take 15.22% of the total patent filing.
North Carolina State University
North Carolina, United States
Patent: 23
University of Kansas Medical Center
Missouri, United States
Patent: 16
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 12
Autonomous University of Barcelona
Northeast Normal University
Jilin Sheng, China
Patent: 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
Overijssel, Netherlands
Patent: 4
South China Normal University
Guangdong Sheng, China
Patent: 4